1. Pre-emptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients 
J. Torre-Cisneros, J.A. Madueño, C. Herrero, M. de la Mata, R. Gonzalez, A. Rivero, G. Miño, P. Sánchez-Guijo 
Clinical Microbiology and Infection 
Volume 8, Issue 12, Pages (December 2002)
DOI: /j x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Trial profile.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions